LANSOPRAZOLE VIATRIS 15 mg, gastro-resistant capsule 30 capsules, CIP 3400930246467
Active ingredients: Lansoprazole
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule30 capsules, CIP 3400930246467orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LANSOPRAZOLE VIATRIS 15 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) avec bouchon(s) applicateur de 30 gélule(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 29 Nov 2022
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60622537CIP73024646CIP133400930246467Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LANSOPRAZOLEgélule | 15 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.